[1] RIVERA-FRANCO M M,LEON-RODRIGUEZ E. Delays in breast cancer detection and treatment in developing countries[J]. Breast Cancer (Auckl),2018,12:117822341775267. [2] LI T, MELLOTHOMS C, BRENNAN P. Descriptive epidemiology of breast cancer in China:incidence, mortality, survival and prevalence[J]. Breast Cancer Res Treat,2016,159(3):395-406. [3] TOT T. Metastasis of breast cancer prior to invasion[J]. Breast Cancer Res Treat,2018,170(1):197. [4] MIZUKAMI Y,FUJIKI K,DUERR E M,et al. Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc[J]. J Biol Chem, 2006, 281(20):13957-13963. [5] RIDLEY A J. Rho GTPase signalling in cell migration[J]. Curr Opin Cell Biol,2015,36:103-112. [6] PARRI M, CHIARUGI P. Rac and Rho GTPases in cancer cell motility control[J]. Cell Commun Signal, 2010,8:23. [7] 卜强,汤华明,谈健,等. 前列腺癌中RhoC和Rho激酶1的表达及其对丝裂原活化蛋白激酶和Akt蛋白的影响[J]. 中华肿瘤杂志,2011,33(3):202-206. [8] HAHMANN C,SCHROETER T. Rho-kinase inhibitors as therapeutics:from pan inhibition to isoform selectivity[J]. Cell Mol Life Sci,2010,67(2):171-177. [9] LIAO J K, SETO M, NOMA K. Rho kinase (ROCK) inhibitors[J]. J Cardiovasc Pharmacol,2007,50(1):17-24. [10] ZHAO X Y,WANG X F,LI L,et al. Effects of high glucose on human umbilical vein endothelial cell permeability and myosin light chain phosphorylation[J]. Diabetol Metab Syndr,2015,7:98. [11] RAN F A, HSU P D, WRIGHT J, et al. Genome engineering using the CRISPR-Cas9 system[J]. Nat Protoc,2013,8(11):2281-2308. [12] LEE D J, KWON M J, NAM E S, et al. Histopathologic predictors of lymph node metastasis and prognosis in tonsillar squamous cell carcinoma[J]. Korean J Pathol,2013,47(3):203-210. [13] FRITZ G, BRACHETTI C, BAHLMANN F, et al. Rho GTPases in human breast tumours:expression and mutation analyses and correlation with clinical parameters[J]. Br J Cancer,2002,87(6):635-644. [14] BOTTINO J, GELALETI G B, MASCHIO L B, et al. Immunoexpression of ROCK-1 and MMP-9 as prognostic markers in breast cancer[J]. Acta Histochem, 2014,116(8):1367-1373. [15] VIGIL D,KIM T Y,PLACHCO A,et al. ROCK1 and ROCK2 are required for non-small cell lung cancer anchorage-independent growth and invasion[J]. Cancer Res, 2012,72(20):5338-5347. [16] SAHAI E, MARSHALL C J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signalling and extracellular proteolysis[J]. Nat Cell Biol, 2003,5(8):711-719. [17] CHEN Y, WANG D, GUO Z, et al. Rho kinase phosphorylation promotes Ezrin-mediated metastasis in hepatocellular carcinoma[J]. Cancer Res, 2011, 71(5):1721-1729. |